The bacteria Bacillus subtilis has been found to prevent α-synuclein build up in C. elegans, offering further support to the idea that the gut microbiome can influence brain activity.
Browsing: gut microbiome
A team of researchers discovered that in mice, short-chain fatty acids found in the gut have the potential to protect brain cells from potential damage due to inflammation following a stroke.
Sex-specific effects of microbiome perturbations in an Alzheimer’s mouse model: an interview with Hemraj Dodiya
At SfN Neuroscience 2019, we had the brilliant opportunity of interviewing Hemraj Dodiya about sex-specific effects of microbiome perturbations in an Alzheimer’s mouse model.
A preclinical study in mice has revealed that a specific miRNA could target and modulate the gut microbiome with precision, holding potential as a new treatment option for multiple sclerosis.
Chinese pharmaceutical firm, Shanghai Green Valley Pharmaceuticals, has gained conditional approval from the country’s regulatory agency for oligomannate as a treatment for mild-to-moderate Alzheimer’s disease.
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.
A new mouse model of Parkinson’s has demonstrated how the disease could spread from the gut to the brain through the vagus nerve.
Long-term antibiotic treatment may reduce the size of amyloid plaques and could alter the appearance of microglia in the brains of male mice.
In this interview, we spoke with Viviane Labrie about her research into the vermiform appendix as a possible contributor to Parkinson’s disease.
Researchers have revealed that a stroke could alter an individual’s microbiome even up to 1 month after it occurs; this has emphasized the importance of incorporating gut health in patient recovery and treatment.